Bloomfield Hills internal medicine physician Amjad Rass was excited to reunite with family in Syria last month for the first ...
GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...
Pete Yonkman, president of Cook Group and Cook Medical, was among the speakers Monday at the official launch of the new ...
GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...
Medical industry giants Eli Lilly and Merck will collaborate with Purdue through a new institute, which aims to advance ...
Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...
The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.
A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...
US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...
Eli Lilly (LLY) closed the latest trading day at $804.99, indicating a -0.39% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 0.92%. At the same ...
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
Eli Lilly (NYSE: LLY) sells a broad variety of drugs across treatment ... four businesses and its solid history of dividend ...